한글목차

경피 약물 전달 시스템 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 400억 1,000만 달러에서 2026년에는 430억 9,000만 달러에 이르고, CAGR 7.7%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 경구용 의약품의 한계, 만성질환의 확산, 환자의 복약 순응도 요구, 패치 기술 개발, 병원 내 약물 전달 시스템 활용 등을 꼽을 수 있습니다.

경피 약물 전달 시스템 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 7.7%의 연평균 복합 성장률(CAGR)로 579억 4,000만 달러에 이를 전망입니다. 예측 기간의 성장 요인으로는 자가투여 요법의 확대, 웨어러블 의료기기의 보급, 만성질환의 부담 증가, 약물 전달 기술의 혁신, 외래 진료의 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 약물 함유 패치 시스템의 채택 확대, 통증 관리 용도 확대, 제어된 약물 방출에 대한 수요, 재택 약물 전달의 성장, 마이크로니들 기술의 혁신 등이 있습니다.

향후 몇 년 동안 만성 질환의 유병률 증가는 경피 약물 전달 시스템 시장의 성장을 견인할 것으로 예측됩니다. 만성질환이란 당뇨병, 심장병 등 지속적인 관리가 필요한 장기적인 건강상태로 일상생활에 제한을 초래할 수 있는 질환을 말합니다. 이러한 질병 증가는 운동량 감소가 체중 증가, 심혈관 질환 위험의 악화, 대사 균형의 붕괴에 기여하는 등 앉아서 생활하는 생활습관 때문인 것으로 분석되고 있습니다. 경피약물전달시스템은 피부를 통해 약물을 지속적이고 제어된 형태로 방출함으로써 환자의 복약 순응도를 높이고 안정적인 치료 수준을 유지한다는 점에서 만성질환 관리에 중요한 역할을 합니다. 예를 들어, 2023년 6월 미국 공중보건 연구기관인 건강지표평가연구소(IHME)가 발표한 보고서에 따르면, 전 세계적으로 5억 명 이상이 당뇨병을 앓고 있으며, 이 숫자는 2050년까지 13억 명으로 두 배 이상 늘어날 것으로 예측됩니다. 따라서 만성질환 증가 추세는 경피약물전달시스템 시장의 확대를 뒷받침하고 있습니다.

경피 약물 전달 시스템 시장의 주요 기업들은 약물 흡수율을 높이고 환자 순응도를 개선하기 위해 마이크로니들 기술 등 기술 혁신에 집중하고 있습니다. 마이크로니들 기술은 기존의 주사를 대체할 수 있는 대안으로 피부를 통해 통증 없이 약물을 주입하는 최소침습적 장치입니다. 예를 들어, 2024년 10월 한국의 대우제약은 마이크로니들 플랫폼 '클로팜(CLOPAM)'을 발표했습니다. 이 기술은 약물 전달 효율을 향상시키고, 주사에 따른 불편함을 줄이며, 약물의 제어된 지속 방출을 가능하게 합니다. 주요 목적은 경구약이나 주사제를 대체할 수 있는 통증이 없고 일관성 있는 대안을 제공하여 환자의 복약 순응도와 치료 결과를 향상시키는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Transdermal drug delivery systems are methods of administering medication through the skin, allowing for controlled and continuous release of the drug into the bloodstream over time. These systems typically come in the form of a patch or similar device that adheres to the skin, gradually delivering medication while offering benefits such as bypassing the digestive system and maintaining consistent drug levels in the body.

The primary formulation types of transdermal drug delivery systems include drug-in-patch, reservoir type, matrix type, and microreservoir type. The drug-in-patch formulation is especially popular in the consumer health sector due to its convenience, notably for treatments like nicotine replacement and hormone therapy patches. Key technologies in transdermal delivery include iontophoresis and microporation. Applications span pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and these systems are utilized across hospitals, home healthcare, pharmaceutical companies, and research institutes.

Tariffs have influenced the transdermal drug delivery systems market by increasing the cost of imported active pharmaceutical ingredients, polymers, and electronic components used in advanced patches and iontophoresis devices, leading to higher manufacturing expenses and pricing pressures. The impact is most significant across drug-in-patch, reservoir, and microreservoir systems, with Asia-Pacific and North American regions being the most affected due to their dependence on cross-border pharmaceutical and medical device supply chains. However, tariffs are also encouraging pharmaceutical companies to localize production, strengthen domestic manufacturing, and invest in supply chain resilience, which is gradually improving regional self-sufficiency and long-term market stability.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including transdermal drug delivery systems industry global market size, regional shares, competitors with a transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $40.01 billion in 2025 to $43.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to oral drug limitations, chronic disease prevalence, patient compliance needs, patch technology development, hospital drug delivery usage.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to self-administered therapy growth, wearable healthcare devices, chronic disease burden, drug delivery innovation, outpatient care expansion. Major trends in the forecast period include growing adoption of drug-in-patch systems, expansion of pain management applications, demand for controlled drug release, growth of home-based drug delivery, innovation in microneedle technology.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the coming years. Chronic diseases are long-term health conditions that require ongoing management, such as diabetes or heart disease, and can limit daily activities. The rise in these diseases is partly due to more sedentary lifestyles, as reduced physical activity contributes to weight gain, poor cardiovascular health, and metabolic imbalances. Transdermal drug delivery systems play a key role in chronic disease management by providing continuous, controlled release of medication through the skin, improving patient adherence and maintaining stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the growing prevalence of chronic diseases is supporting the expansion of the transdermal drug delivery systems market.

Key companies in the transdermal drug delivery systems market are focusing on technological innovations, such as microneedle technology, to enhance drug absorption and improve patient compliance. Microneedle technologies are minimally invasive devices that deliver drugs painlessly through the skin, providing an alternative to traditional injections. For instance, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This technology improves drug delivery efficiency, reduces the discomfort associated with injections, and enables controlled, sustained release of medication. Its primary goal is to provide a painless, consistent alternative to oral or injectable medications, enhancing both patient adherence and treatment outcomes.

In August 2024, Insud Pharma S.L., a Spain-based global pharmaceutical company, acquired Agile Therapeutics Inc. for approximately $0.045 billion. This acquisition enables Insud Pharma to strengthen its women's health and transdermal drug delivery capabilities by integrating Agile's flagship product, Twirla, a transdermal contraceptive patch delivering levonorgestrel and ethinyl estradiol through the skin. Agile Therapeutics Inc., based in the US, specializes in women's healthcare and transdermal drug delivery technologies.

Major companies operating in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH, Cipla Ltd., Sun Pharmaceutical Industries Ltd., Luye Pharma Group, Mundipharma International Ltd., Aveva Drug Delivery Systems Ltd.

North America was the largest region in the transdermal drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transdermal drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
• 2) By Technology: Iontophoresis; Microporation
• 3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
• 4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
• Subsegments:
• 1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
• 2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
• 3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
• 4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Novartis AG; 3M Company; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Skyepharma PLC; Noven Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co. Inc.; Watson Pharmaceuticals Inc.; Endo International plc; Transdermal Technologies Inc.; Actavis Inc.; LTS Lohmann Therapie-Systeme AG; Perrigo Company plc; Nitto Denko Corporation; Zydus Lifesciences Ltd.; Dr. Reddy's Laboratories Ltd.; Sandoz International GmbH; Cipla Ltd.; Sun Pharmaceutical Industries Ltd.; Luye Pharma Group; Mundipharma International Ltd.; Aveva Drug Delivery Systems Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Transdermal Drug Delivery Systems Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Transdermal Drug Delivery Systems Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Transdermal Drug Delivery Systems Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Transdermal Drug Delivery Systems Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Growing Adoption Of Drug-In-Patch Systems
  • 4.2.2 Expansion Of Pain Management Applications
  • 4.2.3 Demand For Controlled Drug Release
  • 4.2.4 Growth Of Home-Based Drug Delivery
  • 4.2.5 Innovation In Microneedle Technology

5. Transdermal Drug Delivery Systems Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Home Healthcare
• 5.3 Pharmaceutical Companies
• 5.4 Research Institutes
• 5.5 Specialty Clinics

6. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transdermal Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Transdermal Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transdermal Drug Delivery Systems Market Segmentation

• 9.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug-In-Patch, Reservoir Type, Matrix Type, Microreservoir Type
• 9.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Iontophoresis, Microporation
• 9.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management, Central Nervous System, Cardiovascular Diseases, Smoking Cessation
• 9.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Home Healthcare, Pharmaceutical Companies, Research Institutes
• 9.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive
• 9.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gel Reservoir Systems, Liquid Reservoir Systems, Solid Reservoir Systems
• 9.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymer Matrix Systems, Lipid Matrix Systems, Hydrogel Matrix Systems
• 9.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microneedle Arrays, Microemulsion Reservoirs, Nanoparticle-Infused Reservoirs

10. Transdermal Drug Delivery Systems Market Regional And Country Analysis

• 10.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transdermal Drug Delivery Systems Market

• 11.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transdermal Drug Delivery Systems Market

• 12.1. China Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transdermal Drug Delivery Systems Market

• 13.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transdermal Drug Delivery Systems Market

• 14.1. Japan Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transdermal Drug Delivery Systems Market

• 15.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transdermal Drug Delivery Systems Market

• 16.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transdermal Drug Delivery Systems Market

• 17.1. South Korea Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transdermal Drug Delivery Systems Market

• 18.1. Taiwan Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transdermal Drug Delivery Systems Market

• 19.1. South East Asia Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transdermal Drug Delivery Systems Market

• 20.1. Western Europe Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transdermal Drug Delivery Systems Market

• 21.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transdermal Drug Delivery Systems Market

• 22.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transdermal Drug Delivery Systems Market

• 23.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transdermal Drug Delivery Systems Market

• 24.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transdermal Drug Delivery Systems Market

• 25.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transdermal Drug Delivery Systems Market

• 26.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transdermal Drug Delivery Systems Market

• 27.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transdermal Drug Delivery Systems Market

• 28.1. North America Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transdermal Drug Delivery Systems Market

• 29.1. USA Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transdermal Drug Delivery Systems Market

• 30.1. Canada Transdermal Drug Delivery Systems Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transdermal Drug Delivery Systems Market

• 31.1. South America Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transdermal Drug Delivery Systems Market

• 32.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transdermal Drug Delivery Systems Market

• 33.1. Middle East Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transdermal Drug Delivery Systems Market

• 34.1. Africa Transdermal Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transdermal Drug Delivery Systems Market Regulatory and Investment Landscape

36. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 36.1. Transdermal Drug Delivery Systems Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Transdermal Drug Delivery Systems Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Transdermal Drug Delivery Systems Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

37. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

• Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH

38. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

40. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 40.1 Transdermal Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Transdermal Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Transdermal Drug Delivery Systems Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer